The isoelectric focusing properties of serum alkaline phosphatase in disease and following prednisolone and phenylbutazone administration in the horse.
article
OA: green
CC0
Abstract
This study was undertaken to ascertain if the isoelectric focusing pattern of serum alkaline phosphatase (AP) from sick horses with high activity is useful for determining its tissue origin. The effect of oral prednisolone and phenylbutazone therapy on this enzyme in healthy horses was also investigated. The sick horses were divided into three groups: hepatic, intestinal and miscellaneous. All sera had approximately thirteen bands of AP activity when focused on agarose gels with a pH gradient of 3.5 to 9.5. All the horses in the liver disease group had greater than 65% of enzyme activity in bands 3 to 7 (counted from the anode) whereas the other two groups had at least 30% and up to 80% of activity in bands 8 to 13. This was true even in the several cases of primary intestinal disease that had additional biochemical evidence of liver damage. All bands were heat sensitive indicating that little if any AP was of small intestinal or renal origin. Oral prednisolone and phenylbutazone for 20 and 12 days respectively had no affect on serum AP activity or isoelectric pattern. We concluded that the AP in bands 3 to 7 is of liver origin but the origin of bands 8 to 13 remains undetermined although small intestinal or renal origin is unlikely. Isoelectric focusing of serum AP shows promise in differentiating cases of primary from secondary liver disease but further studies are required correlating serum patterns and tissue patterns in animals with diseases.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (30)
- doi:10.1111/j.2042-3306.1984.tb01909.x via openalex
- doi:10.1159/000459078 via openalex
- doi:10.1111/j.1939-165x.1983.tb00609.x via openalex
- doi:10.1016/0009-8981(87)90005-2 via openalex
- doi:10.1016/s0009-9120(87)80002-4 via openalex
- doi:10.1111/j.2042-3306.1983.tb01745.x via openalex
- doi:10.1002/hep.1840030423 via openalex
- W1034625 via openalex
- doi:10.2460/ajvr.1987.48.09.1343 via openalex
- doi:10.1016/s0034-5288(18)33146-1 via openalex
- W2396231908 via openalex
- W2413881882 via openalex
- W2419109325 via openalex
- W2473712114 via openalex
- doi:10.3382/ps.0530957 via openalex
- doi:10.1002/hep.1840050124 via openalex
- doi:10.1136/vr.112.26.599 via openalex
- doi:10.1111/j.1439-0442.1988.tb00002.x via openalex
- doi:10.1111/j.1939-165x.1983.tb00613.x via openalex
- doi:10.1136/vr.106.3.68 via openalex
- doi:10.1042/bj2440001 via openalex
- doi:10.1093/clinchem/33.6.830 via openalex
- doi:10.2460/ajvr.1980.41.12.2076 via openalex
- doi:10.1016/0006-291x(85)90575-3 via openalex
- doi:10.1016/0009-8981(83)90211-5 via openalex
- doi:10.1177/030098588702400402 via openalex
- doi:10.1111/j.1439-0442.1988.tb00001.x via openalex
- doi:10.1093/clinchem/29.4.634 via openalex
- doi:10.1093/clinchem/33.12.2171 via openalex
- doi:10.2460/ajvr.1981.42.04.674 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T11:13:26.172743+00:00
License: CC0
· commercial use OK